Australia markets closed
  • ALL ORDS

    7,771.80
    +43.30 (+0.56%)
     
  • ASX 200

    7,558.10
    +46.50 (+0.62%)
     
  • AUD/USD

    0.6924
    -0.0157 (-2.22%)
     
  • OIL

    73.23
    -2.65 (-3.49%)
     
  • GOLD

    1,865.90
    -50.40 (-2.63%)
     
  • BTC-AUD

    33,869.53
    -273.68 (-0.80%)
     
  • CMC Crypto 200

    535.42
    -1.43 (-0.27%)
     
  • AUD/EUR

    0.6411
    -0.0074 (-1.14%)
     
  • AUD/NZD

    1.0935
    +0.0005 (+0.05%)
     
  • NZX 50

    12,197.15
    +44.99 (+0.37%)
     
  • NASDAQ

    12,573.36
    -229.78 (-1.79%)
     
  • FTSE

    7,901.80
    +81.64 (+1.04%)
     
  • Dow Jones

    33,926.01
    -127.93 (-0.38%)
     
  • DAX

    15,476.43
    -32.76 (-0.21%)
     
  • Hang Seng

    21,660.47
    -297.89 (-1.36%)
     
  • NIKKEI 225

    27,509.46
    +107.41 (+0.39%)
     

Is Anavex Life Sciences a Smart Stock to Buy Now?

Is Anavex Life Sciences a Smart Stock to Buy Now?

Shares of clinical-stage biotechnology company Anavex Life Sciences (NASDAQ: AVXL) recently shot higher. Investors reacting to great news for its Alzheimer's disease drug candidate, blarcamesine, drove the stock about 40% higher when the market opened on Friday, Dec. 2. Is Anavex Life Sciences a smart stock to buy now, or will the road ahead be a rocky one full of potholes?